Discovery of tumor markers through platelet proteomics

Discovery of tumor markers through platelet proteomics - Platelet tumor markers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40446

Enrollment

Registered

2014-06-18

Start date

2014-09-29

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer malignancy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients with stage I&II lung and pancreatic malignancies who are eligible for surgical resection. -Age >18 years -Histologically confirmed adenocarcinoma -Hb >5.6 mmol/L

Exclusion criteria

Exclusion criteria: -Use of any platelet-influencing drug during two weeks prior to blood collection -Patients with congenital platelet disorder -Blood or platelet transfusion during two weeks prior to blood collection -Inflammatory diseases or diabetes -Serious non-healing wound, ulcer, or bone fracture -Pregnancy or breast-feeding -Interference with other research projects

Design outcomes

Primary

Measure	Time frame
Net change in platelet angiogenic proteome after surgery.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results